Abstract
A 70 YEAR OLD DIABETIC MALE WITH POST COVID-19 MUCORMYCOSIS- A CASE REPORT
Prof. Nazneen Mahmood*, Prof. Md. Rashidul Hassan, Prof. Firoz Ahmed Quraishi, Dr. Md. Mahmudur Rahman Siddiqui, Dr. Rubayat Sheikh Giasuddin, Dr. Md. Nasir Uddin Ahmed, Dr. Shamima Islam Shumi, Dr. Md. Abdur Rashid
ABSTRACT
The most common causes attributed to the rise of mucormycosis in COVID-19 patients are uncontrolled diabetes, the excessive use of corticosteroids for immunosuppression, and long term stays in the intensive care unit. Even though no official figures about mucormycosis in COVID-19 cases were released by the Union Health Ministry during the first wave of COVID-19, India contributed to approximately 71% of the global cases of mucormycosis in patients with COVID-19 based on published literature from December, 2019, to the start of April, 2021. Bangladesh has reported two cases of mucormycosis at BIRDEM Hospital in patients who have recovered from Covid-19, a worrying sign as neighboring India reports widespread infections. One of the patients, aged 45 was detected on May 8 and the other, aged 60, was detected on May 23. Here we present a 70 year old diabetic male, who has recovered from Covid-19 and presented with severe respiratory distress, fever and cough. He received steroid, Tocillizumab and Ramdisivir as treatment of Covid in another hospital. He had neutrophilic leukocytosis, thrombocytopenia, acute kidney injury, very high inflammatory markers, CXR(Chest X-Ray) demonstrated bilateral peripheral patchy opacities, RT-PCR(Real Time Polymerase Chain Reaction) for COVID-19 was negative, Bronchoscopy revealed black and white fungus and histopathology confirmed Mucormycosis. He was treated accordingly and subsequently improved. He was discharged with treatment and advice. Since the world has a greater population of diabetic patients in most regions and steroid therapy being used as a potential drug for COVID-19 infection, the warmer and humid regions where COVID-19 and diabetes are prevailing can be an immediate health hazard, especially in low-income and middle-income countries.
[Full Text Article] [Download Certificate]WJPLS CITATION
All | Since 2020 | |
Citation | 590 | 424 |
h-index | 12 | 10 |
i10-index | 17 | 14 |
INDEXING
NEWS & UPDATION
BEST ARTICLE AWARDS
World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Article of current issue
Download Article : Click here